• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » Year in review: 2014 was the year of the medtech IPO

Year in review: 2014 was the year of the medtech IPO

December 10, 2014 By MassDevice staff

Year in review: 2014 was the year of the medtech IPO

Click to enlarge

It was, as predicted, the year of the IPO for medical device companies, with 25 filing initial public offerings during 2014, according to a MassDevice.com analysis.

That’s a dramatic change from 2013, when just 4 companies filed for IPOs, according to VentureSource.

The frothy market isn’t just a win for investors in those newly public companies, because the favorable market conditions can increase valuations on M&A deals and provide another exit pathway for venture capitalists, which could in turn promote much-needed investment in the medtech space.

In 2013, the medical device industry saw just $2.5 billion invested in the space, making it the quietest year medical device investments since 2005.

“For medtech, exits have been phenomenal this year," Matthew Dolan, director of business development for Volcano (NSDQ:VOLC), said recently at our DeviceTalks West event. "We haven’t seen a year like this since, I don’t know, 2007, 2008, somewhere in there."

"If you’re a banker, you’re going around jazzed about how everything has been up probably on average about 30% or 40%, a couple pricing above range for the 1st time in a while and really doing well. I think that window is officially open," added Dolan, who was a banker with the Newport beach, Calif. investment firm Roth Capital Partners before joining Volcano.

Investors ought to be jazzed, too, with the return on their investments. The top 5 IPOs of the year returned a collective 36.3% on their offering prices, led by the largest of the year (see list below).

Nevro Corp. (NYSE:NVRO), which closed its initial public offering in early November with $144.9 million raised from issuing 8.05 million shares at $18 apiece, boasting the year’s top-grossing medical device IPO and its biggest return (90% as of market’s close yesterday). The Menlo Park, Calif.-based company was founded in 2006 and has been led since 2011 by ex-Medtronic (NYSE:MDT) COO Michael DeMane. The company has raised more than $153 million so far from backers including Johnson & Johnson (NYSE:JNJ), Covidien (NYSE:COV), Novo Nordisk and New Enterprise Assoc. A Series C round brought in $48 million last year.

Here’s a look at the Top 5 IPOs this year by gross amount (including any over-allotments), with their share price as of Dec. 9, 2014 and their return on the IPO price:

  • Nevro Corp. (NYSE:NVRO): $144.9 million, $34.20 (+90.0%)
  • K2M Group (NSDQ:KTWO): $132.4 million, $19.52 (+30.1%)
  • TriVascular Technologies (NSDQ:TRIV): $89.7 million, $13.48 (+12.3%)
  • Sientra (NSDQ:SIEN): $86.3 million, $16.51 (+10.1%)
  • Ocular Therapeutix (NSDQ:OCUL): $74.8 million, $18.04 (+38.8%)
  • The boost in IPOs in 2014 was not unexpected; in late 2013 Renaissance Capital predicted a robust year for public offerings.

    "We anticipate another dynamic year for the US IPO market in 2014," Renaissance wrote in its annual wrap-up report. "With positive investor sentiment, low volatility levels and improving economic conditions setting the stage for another strong year for U.S. stocks, we expect the US IPO market to remain healthy in 2014."

    Filed Under: Initial Public Offering (IPO), News Well, Wall Street Beat Tagged With: 2014, Johnson and Johnson, K2M, Nevro Corp., oculartherapeutix, Sientra, TriVascular, Volcano Corp.

    In case you missed it

    • CeQur is launching a discreet, convenient ‘wearable insulin pen’
    • Teva appoints former Vertex exec as new head of R&D, CMO
    • Enovis partners with Kelvi on hot and cold therapies
    • West Pharmaceutical Services debuts new needle syringe system
    • Titan Medical names Cary G. Vance as new president, CEO
    • Acutus completes first closing in left-heart access portfolio sale to Medtronic
    • FDA clears Intuitive, Siemens Healthineers imaging integration for robotic bronchoscopy
    • FDA backs COVID-19 boosters with BA.4/5 spike proteins for fall
    • How safe is health information after the overturning of Roe?
    • Smith+Nephew opens new plant in Malaysia
    • BD launches combination COVID-19, flu, RSV diagnostic test
    • Zimmer Biomet creates independent nonprofit organization to reduce health disparities
    • Dexcom focuses on early diabetes diagnosis as COVID links emerge
    • Nasdaq grants Titan Medical 180-day extension to regain compliance
    • Aerin Medical reports positive 4-year results for VivAer treatment
    • Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
    • How medical device companies are responding to abortion bans

    RSS From Medical Design & Outsourcing

    • Supply Chain EVP Greg Smith sees fewer suppliers in Medtronic’s future
      All eyes are on Medtronic’s global operations and supply chain leader as he works to modernize its operations and scrutinize suppliers. EVP of Global Operations and Supply Chain Greg Smith anticipates fewer suppliers in Medtronic’s future, he said in an interview this week. Smith spoke with DeviceTalks Editorial Director Tom Salemi in his first published… […]
    • CeQur is launching a discreet, convenient ‘wearable insulin pen’
      CeQur designed its Simplicity device to make insulin delivery as seamless as possible for people with diabetes. When it comes to managing diabetes, CeQur wants to make insulin therapy as convenient as possible. For those who prefer to manage their own insulin delivery, the Simplicity device might just do exactly that. Simplicity, a wearable, disposable… […]
    • Meddux opens new facility in Colorado
      Engineering, design, development and manufacturing company Meddux announced that it opened a new facility in Boulder, Colorado. The new, 22,000-square-foot facility doubles the overall square footage from its previous location in Colorado. According to a news release, it helps the company to quadruple its product development area and double its manufacturing footprint. Meddux’s new facility… […]
    • Reducing the Overall Cost of Validation
      By PTI Engineered Plastics Reliable medical devices and equipment are essential for researchers and doctors to accurately diagnose and treat a wide range of diseases. That is why there is such stringent oversight from the FDA to ensure these products meet the necessary requirements and specifications. To ensure compliance with regulators, manufacturers follow installation qualification… […]
    • BBS Automation has a deal to buy medtech supplier Kahle Automation
      BBS Automation said it plans to purchase high-speed automation supplier Kahle Automation to expand its medtech and life sciences business. Kahle will operate as Kahle – a BBS Company, according to a news release from Munich, Germany-based BBS and Lombardy, Italy-based Kahle. The deal is subject to regulatory approval. Terms were not disclosed. Kahle’s co-owners —… […]
    • How safe is health information after the overturning of Roe?
      The U.S. Department of Health and Human Services today issued guidance meant to better protect women’s health information as state abortion bans kick in after the U.S. Supreme Court’s overturning of Roe v. Wade. Despite the HHS actions, women may still wonder whether their health information is entirely safe going forward — a potential challenge… […]
    • Dexcom focuses on early diabetes diagnosis as COVID links emerge
      New evidence is showing that COVID-19 may increase a person’s risk of diabetes, but it could be years until we know for sure. In the meantime, Dexcom (Nasdaq:DXCM) is getting ready, VP of Global Clinical Initiatives Tomas Walker said. Walker recently spoke with Medical Design & Outsourcing to discuss the San Diego-based diabetes device developer’s… […]
    • Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
      Blackrock Neurotech and the University of Pittsburgh’s Rehab Neural Engineering Labs (Pitt RNEL) are working together on the first portable brain-computer interface (BCI) to allow patients to participate in research trials from home. A Blackrock representative said it’s the final step as the company prepares to launch its first commercial product early next year. Salt… […]
    • How medical device companies are responding to abortion bans
      Days after the U.S. Supreme Court’s decision to overturn Roe v. Wade’s protection of abortion rights, medical device companies are among those reassuring workers about healthcare access. Corporate communications to employees and the public at large come as trigger laws in nearly half of the states outlaw abortion immediately. Some medtech companies are not using… […]
    • Philips updates on testing results for recalled ventilators
      Royal Philips (NYSE:PHG) says only a small portion of returned respiratory devices displayed the sound abatement foam degradation that sparked a massive recall. Repeated ozone cleaning may have made the problem worse. Those were some of the major takeaways from an update Philips provided today on a comprehensive test and research program it implemented after its… […]
    • ResMed names Lucile Blaise as new Sleep & Respiratory Care leader
      Lucile Blaise will be the new president of ResMed’s Sleep & Respiratory Care business starting July 1, ResMed (NYSE: RMD) said today. She replaces Jim Hollingshead, who became president and CEO of Insulet (Nasdaq:PODD) on June 1. ResMed President and COO Rob Douglas is serving as interim president of the Sleep & Respiratory Care during… […]

    Leave a Reply

    You must be logged in to post a comment.

    Primary Sidebar

    DeviceTalks Weekly

    July 1, 2022
    Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
    See More >

    MEDTECH 100 INDEX

    Medtech 100 logo
    Market Summary > Current Price
    The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
    Need Medtech news in a minute?
    We Deliver!

    MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

    MDO ad

    Footer

    MASSDEVICE MEDICAL NETWORK

    DeviceTalks
    Drug Delivery Business News
    Medical Design & Outsourcing
    Medical Tubing + Extrusion
    Drug Discovery & Development
    Pharmaceutical Processing World
    MedTech 100 Index
    R&D World

    Device Talks Webinars, Podcasts, & Discussions

    Attend our Monthly Webinars
    Listen to our Weekly Podcasts
    Join our Device Talks Tuesdays Discussion

    MASSDEVICE

    Subscribe to MassDevice E-Newsletter
    Advertise with us
    About
    Contact us
    Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

    Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
    The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

    Advertise | Privacy Policy | RSS